Diebold Nixdorf Valuation
Is DBD undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
5/6Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of DBD when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: DBD (€2.96) is trading below our estimate of fair value (€41.39)
Significantly Below Fair Value: DBD is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for DBD?
Key metric: As DBD is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is DBD's PS Ratio? | |
|---|---|
| PS Ratio | 0.07x |
| Sales | US$3.70b |
| Market Cap | US$241.93m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.6x |
| Enterprise Value/EBITDA | 10.9x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does DBD's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 2.2x | ||
JY0 ParTec | 7.1x | 36.6% | €700.0m |
HYI Hyrican Informationssysteme | 1x | n/a | €25.7m |
M3BK Pyramid | 0.3x | 8.8% | €20.8m |
C3RY Cherry | 0.1x | 1.8% | €16.2m |
DBD Diebold Nixdorf | 0.07x | 3.0% | €241.9m |
Price-To-Sales vs Peers: DBD is good value based on its Price-To-Sales Ratio (0.1x) compared to the peer average (1.1x).
Price to Sales Ratio vs Industry
How does DBD's PS Ratio compare vs other companies in the European Tech Industry?
Price-To-Sales vs Industry: DBD is good value based on its Price-To-Sales Ratio (0.1x) compared to the European Tech industry average (0.8x).
Price to Sales Ratio vs Fair Ratio
What is DBD's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 0.07x |
| Fair PS Ratio | 0.7x |
Price-To-Sales vs Fair Ratio: DBD is good value based on its Price-To-Sales Ratio (0.1x) compared to the estimated Fair Price-To-Sales Ratio (0.7x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
JEOL
JP¥279.2b
Engages in the research, development, manufacture, and marketing of scientific and metrology instruments, semiconductor and industrial equipment, and medical equipment worldwide.
JEL
JP¥34.60
7D
0%
1Y
-2.3%
UniDevice
€1.8m
Together with its subsidiary, PPA International AG, engages in wholesale of electronic entertainment and communication devices.
UDC
€0.12
7D
0%
1Y
-92.0%
KATEK
€221.7m
Provides electronics value chain services in Germany, Europe, and internationally.
KTEK
€15.10
7D
0%
1Y
1.0%